News
A trial pitting weight loss jab Mounjaro against competitor Wegovy ended with one clear winner, and Mounjaro is getting ...
Weight loss drugs, including Wegovy (semaglutide) and Mounjaro (tirzepatide), are becoming increasingly popular among those ...
Mounjaro will soon be available on the NHS across the UK but it's important patients avoid the dangerous 'golden dose' trend ...
Novo Nordisk sees soaring demand for Ozempic and Wegovy as label expansions and manufacturing boosts fuel obesity market ...
Previous clinical studies suggested that - when combined with changes to their diet, exercise and behavioural support - Wegovy users could lose more than 10% of their body weight after a year on the ...
WITH Mounjaro users shedding nearly double the amount of weight compared to its other counterparts, it’s no wonder the ...
Simon Cork does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...
Weight loss drugs, including Wegovy (semaglutide) and Mounjaro (tirzepatide), are becoming increasingly popular among those trying to lose weight. But ...
A federal judge on Wednesday ruled that the Food and Drug Administration’s (FDA) decision to remove popular GLP-1s from its drug shortage list, ending the sale of compounded versions of the ...
The side effects of taking Mounjaro can be very varied, and the drug tends to affect people differently. The most common side effects include feeling sick, diarrhoea, constipation, vomiting, heartburn ...
My GP, who has supported me through everything, agreed that I was a good candidate for weight-loss medication, and I started on Wegovy late in 2023 ... In December 2024, I switched to Mounjaro. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results